Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Aquestive Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −8 vs. Q3 2022
- Shares held
- 14.9M
- −970.7K (−6.1%) vs. Q3 2022
- Total value
- $13.5M
- −$5.13M (−27.6%) vs. Q3 2022
- New holders
- 4
- 5 more added
- Sold out
- 12
- 12 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AQST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $299.5M |
| Q1 2026 | 180 | $298.6M |
| Q4 2025 | 179 | $467.0M |
| Q3 2025 | 152 | $369.3M |
| Q2 2025 | 117 | $157.6M |
| Q1 2025 | 121 | $127.8M |
| Q4 2024 | 114 | $154.4M |
| Q3 2024 | 117 | $232.4M |
| Q2 2024 | 98 | $110.7M |
| Q1 2024 | 97 | $176.8M |
| Q4 2023 | 57 | $48.1M |
| Q3 2023 | 48 | $21.5M |
| Q2 2023 | 54 | $31.5M |
| Q1 2023 | 35 | $17.0M |
| Q4 2022 | 37 | $13.5M |
| Q3 2022 | 46 | $18.6M |
| Q2 2022 | 46 | $10.7M |
| Q1 2022 | 51 | $40.6M |
| Q4 2021 | 52 | $62.9M |
| Q3 2021 | 46 | $64.4M |
| Q2 2021 | 60 | $62.0M |
| Q1 2021 | 64 | $86.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aquestive Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 185 | $0 | 0.00% | −2,262−92.4% | Reduced |
| Coppell Advisory Solutions LLC | 37 | $33 | 0.00% | +37 | New |
| Coppell Advisory Solutions Corp. | 37 | $33 | 0.00% | +37 | New |
| Bank of America Corp | 102 | $92 | 0.00% | −482−82.5% | Reduced |
| NewSquare Capital LLC | 130 | $117 | 0.00% | +130 | New |
| TCI Wealth Advisors, Inc. | 500 | $451 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 1,000 | $902 | 0.00% | 00.0% | Unchanged |
| Richard W. Paul & Associates, LLC | 1,423 | $1.28K | 0.00% | +1,423 | New |
| Rockefeller Capital Management L.P. | 3,166 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,910 | $2.63K | 0.00% | −15,153−83.9% | Reduced |
| Tower Research Capital LLC (TRC) | 4,995 | $5.00K | 0.00% | −29,880−85.7% | Reduced |
| Morgan Stanley | 5,672 | $5.12K | 0.00% | −27,709−83.0% | Reduced |
| Wells Fargo & Company | 11,377 | $10.3K | 0.00% | −9,989−46.8% | Reduced |
| D.B. Root & Company, LLC | 12,500 | $11.3K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 14,853 | $13.4K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 20,730 | $18.7K | 0.00% | +3,000+16.9% | Added |
| Group One Trading, L.P. | 24,261 | $21.9K | 0.00% | −5,681−19.0% | Reduced |
| Financial Advocates Investment Management | 32,000 | $28.9K | 0.00% | +5,000+18.5% | Added |
| Two Sigma Advisers, LP | 32,400 | $29.2K | 0.00% | −7,500−18.8% | Reduced |
| Millennium Management LLC | 46,280 | $42.0K | 0.00% | −429,591−90.3% | Reduced |
| Beacon Pointe Advisors, LLC | 60,000 | $54.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 62,090 | $56.0K | 0.00% | 00.0% | Unchanged |
| Man Group plc | 89,900 | $81.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 96,037 | $86.6K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 130,305 | $117.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 142,956 | $129.0K | 0.00% | 00.0% | Unchanged |
| Latash Investments, LLC | 243,134 | $219.3K | 0.18% | 00.0% | Unchanged |
| BlackRock Inc. | 357,715 | $322.7K | 0.00% | −16,163−4.3% | Reduced |
| Geode Capital Management, LLC | 387,575 | $349.0K | 0.00% | +21,676+5.9% | Added |
| Bracebridge Capital, LLC | 428,571 | $386.6K | 0.15% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 462,737 | $417.0K | 0.00% | −438,063−48.6% | Reduced |
| Schonfeld Strategic Advisors LLC | 506,600 | $457.0K | 0.00% | +99,900+24.6% | Added |
| Vahanian & Associates Financial Planning Inc. | 678,258 | $611.9K | 2.00% | −17,000−2.4% | Reduced |
| Vanguard Group Inc | 1,244,732 | $1.12M | 0.00% | +63,192+5.3% | Added |
| Bratton Capital Management, L.P. | 9,810,958 | $8.85M | 100.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 6,500 | – | – | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −27,704−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −23,850−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −20,318−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −20,087−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −13,704−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −10,235−100.0% | Sold out |
| Running Point Capital Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −9,068−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,751−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −499−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −410−100.0% | Sold out |
| Strategic Asset Management, LLC | – | – | – | – | Not filed |